Your browser doesn't support javascript.
loading
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study).
Makker, Vicky; Recio, Fernando O; Ma, Ling; Matulonis, Ursula A; Lauchle, Jennifer O; Parmar, Hema; Gilbert, Houston N; Ware, Joseph A; Zhu, Rui; Lu, Shan; Huw, Ling-Yuh; Wang, Yulei; Koeppen, Hartmut; Spoerke, Jill M; Lackner, Mark R; Aghajanian, Carol A.
Afiliación
  • Makker V; Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Recio FO; Weill Cornell Medical College, New York, New York.
  • Ma L; South Florida Center for Gynecologic Oncology, Boca Raton, Florida.
  • Matulonis UA; Rocky Mountain Cancer Centers, Lakewood, Colorado.
  • Lauchle JO; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Parmar H; Genentech Inc, South San Francisco, California.
  • Gilbert HN; Genentech Inc, South San Francisco, California.
  • Ware JA; Genentech Inc, South San Francisco, California.
  • Zhu R; Genentech Inc, South San Francisco, California.
  • Lu S; Genentech Inc, South San Francisco, California.
  • Huw LY; Genentech Inc, South San Francisco, California.
  • Wang Y; Genentech Inc, South San Francisco, California.
  • Koeppen H; Genentech Inc, South San Francisco, California.
  • Spoerke JM; Genentech Inc, South San Francisco, California.
  • Lackner MR; Genentech Inc, South San Francisco, California.
  • Aghajanian CA; Genentech Inc, South San Francisco, California.
Cancer ; 122(22): 3519-3528, 2016 Nov 15.
Article en En | MEDLINE | ID: mdl-27603005

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials Idioma: En Revista: Cancer Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials Idioma: En Revista: Cancer Año: 2016 Tipo del documento: Article